The research published in Alzheimer’s and Dementia: Translational Research & Clinical Interventions found that certain ...

There’s currently no cure for Alzheimer’s. The FDA-approved medications fall into two categories: drugs for symptom ...

The Food and Drug Administration announced last week that it will revoke authorization for FD&C Red No. 3 in food and ...

A major new study has revealed a long list of benefits and some little-known risks of Ozempic and other GLP-1 medications.

University Hospitals Brain Health & Memory Center is now treating patients with KISUNLA™ (donanemab), a Food and Drug ...

It’s unconscionable that more than four years since this began, we still don’t have one FDA-approved drug,” said Meighan ...

Hayes is one of millions of Americans who suffer from long COVID. Depending on the patient, the condition can rob someone of ...

In an analysis of health data from 130million people, British researchers found medications which could potentially increase, ...

EXISTING drugs already dished out on the NHS could slash dementia risk, a new study has revealed. While new drugs are ...

Red No. 3, chemically known as erythrosine, was first introduced into foods in 1907. Companies subsequently added it to ...

Zunveyl, an oral medication, is a better-tolerated version of galantamine for managing mild to moderate Alzheimer's symptoms.

A non-opioid painkiller from Vertex Pharmaceuticals could become a blockbuster, but questions remain on whether it will prove ...